STOCK TITAN

Titan International recasts results to exclude ITM

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Titan International, Inc. (TWI) provided supplemental historical financial information recast to present its ITM business as discontinued operations, so readers can evaluate continuing-operations results. Titan had agreed to sell ITM under a Sale and Purchase Agreement entered September 21, 2026. Beginning with the 10-Q for the quarter ended September 30, 2026, ITM results are presented as discontinued operations. The supplemental tables cover the first and second quarters of 2026 and the corresponding 2025 quarters.

For the three months ended June 30, 2026, net sales were $366.290 million, compared with $344.557 million a year earlier; continuing-operations net loss was $1.262 million, versus $6.846 million. Adjusted EBITDA from continuing operations was $22.214 million, compared with $18.946 million. For the three months ended March 31, 2026, continuing-operations net loss was $27.729 million, versus $3.836 million in 2025, and net cash used in continuing operating activities was $40.464 million, versus $32.509 million. In the June 2026 quarter, continuing operating activities provided net cash of $30.255 million, compared with $15.440 million a year earlier.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

How the balance works

Positive

  • Moderate pointQ2 net sales were $366.290 million, versus $344.557 million in 2025.
  • Moderate pointQ2 continuing-operations adjusted EBITDA was $22.214 million, versus $18.946 million in 2025.

Negative

  • Moderate pointQ1 continuing-operations net loss was $27.729 million, versus $3.836 million in 2025.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Net sales $366.290 million Three months ended June 30, 2026; $344.557 million for the comparable 2025 quarter
Net loss from continuing operations $1.262 million loss Three months ended June 30, 2026; $6.846 million loss for the comparable 2025 quarter
Adjusted EBITDA from continuing operations $22.214 million Three months ended June 30, 2026; $18.946 million for the comparable 2025 quarter; non-GAAP measure
Net loss from continuing operations $27.729 million loss Three months ended March 31, 2026; $3.836 million loss for the comparable 2025 quarter
Net cash provided by operating activities of continuing operations $30.255 million Three months ended June 30, 2026; $15.440 million for the comparable 2025 quarter
Net cash used for operating activities of continuing operations $40.464 million Three months ended March 31, 2026; $32.509 million for the comparable 2025 quarter
Net income attributable to Titan and applicable to common shareholders $5.764 million Three months ended June 30, 2026; a $4.545 million loss for the comparable 2025 quarter
discontinued operations financial
"historical results of the ITM business are presented as discontinued operations"
Discontinued operations are parts of a company that it has decided to sell or shut down, and no longer plans to run in the future. This matters to investors because it helps them understand which parts of the business are ongoing and which are being phased out, providing a clearer picture of the company’s current performance and future prospects. Think of it like a store closing a department—it no longer contributes to sales or profits.
adjusted EBITDA financial
"Adjusted EBITDA from continuing operations"
Adjusted EBITDA is a way companies measure how much money they make from their core operations, like running a business, by removing certain costs or income that aren’t part of regular business activities. It helps investors see how well a company is doing without distractions from unusual expenses or gains, making it easier to compare companies or track performance over time.
EBITDA financial
"reconciliation of net loss to EBITDA and adjusted EBITDA"
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It measures a company's profitability by focusing on the money it makes from its core operations, ignoring expenses like taxes and accounting adjustments. Investors use EBITDA to compare how well different companies are performing financially, as it provides a clearer picture of operational success without the influence of financial structure or accounting choices.
non-GAAP financial measures financial
"EBITDA and adjusted EBITDA, which are non-GAAP financial measures"
Non-GAAP financial measures are numbers companies use to show their financial performance that exclude certain expenses or income. They help investors see how the company might perform without one-time costs or other unusual items, giving a different perspective from official reports. However, since they can be adjusted, they don’t always tell the full story and should be looked at alongside standard financial figures.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were TWI's Q2 2026 net sales and adjusted EBITDA?

Net sales were $366.290 million, and adjusted EBITDA from continuing operations was $22.214 million for the three months ended June 30, 2026. The comparable 2025 amounts were $344.557 million and $18.946 million, respectively.

Why did Titan provide recast financial statements?

Titan said the supplemental information was provided to assist investors in evaluating continuing operations. It retrospectively reflects the ITM business as discontinued operations for the three months ended March 31 and June 30, 2026 and 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0000899751False00008997512026-11-132026-11-13

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): November 13, 2026

TITAN INTERNATIONAL, INC.
(Exact name of Registrant as specified in its Charter)

Delaware1-1293636-3228472
(State of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

1525 Kautz Road, Suite 600, West Chicago, IL  60185
(Address of principal executive offices) (Zip Code)

(630) 377-0486
(Registrant's telephone number, including area code)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol
Name of each exchange on which registered
Common stock, $0.0001 par valueTWINew York Stock Exchange





Item 8.01 Other Events.

As previously disclosed, on September 21, 2026, Titan International, Inc. (the “Company”) entered into a Sale and Purchase Agreement (the “Purchase Agreement”) pursuant to which the Company agreed to sell its ITM business. Beginning with the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, the historical results of the ITM business are presented as discontinued operations.

To assist investors in evaluating the Company’s continuing operations, the Company is providing supplemental historical financial information for the three months ended March 31, 2026 and 2025, and the three months ended June 30, 2026 and 2025, retrospectively revised to reflect the ITM business as discontinued operations. This supplemental financial information is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1
Unaudited supplemental historical financial information for the three months ended March 31, 2026 and 2025, and the three months ended June 30, 2026 and 2025, retrospectively revised to reflect the ITM business as discontinued operations.








SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.




TITAN INTERNATIONAL, INC.
(Registrant)

Date:November 13, 2026
By:
/s/ TONY C. EHELI
Tony C. Eheli
SVP and Chief Financial Officer
(Principal Financial Officer)







Exhibit 99.1
TITAN INTERNATIONAL, INC.
Unaudited Condensed Consolidated Statements of Operations
Recast for Discontinued Operations
(All amounts in thousands, except per share data)
Three months ended
June 30, 2026
March 31, 2026
June 30, 2025
March 31, 2025
Net sales
$
366,290 
$
395,153 
$
344,557 
$
384,956 
Cost of sales
309,522 
337,078 
292,034 
329,458 
Gross profit
56,768 
58,075 
52,523 
55,498 
Selling, general, and administrative expenses
44,558 
44,235 
44,968 
42,984 
Research and development expenses
3,711 
3,159 
2,805 
2,830 
Royalty expense
2,653 
2,410 
2,419 
2,446 
Restructuring and other charges
834 
25,142 
— 
— 
Income (loss) from operations
5,012 
(16,871)
2,331 
7,238 
Interest expense
(10,054)
(9,887)
(9,674)
(9,534)
Interest income
2,317 
1,898 
2,094 
1,950 
Foreign exchange loss
(75)
(321)
(1,969)
(819)
Other income
506 
756 
993 
697 
Loss from continuing operations before income taxes
(2,294)
(24,425)
(6,225)
(468)
(Benefit) provision for income taxes
(1,032)
3,304 
621 
3,368 
Net loss from continuing operations
(1,262)
(27,729)
(6,846)
(3,836)
Net income from discontinued operations, net of tax
7,602 
3,479 
3,242 
3,858 
Net income (loss)
6,340 
(24,250)
(3,604)
22 
Net income (loss) attributable to noncontrolling interests
576 
(36)
941 
671 
Net income (loss) attributable to Titan and applicable to common shareholders
$
5,764 
$
(24,214)
$
(4,545)
$
(649)
(Loss) earnings per common share:
Basic net loss from continuing operations per share
$
(0.02)
$
(0.43)
$
(0.11)
$
(0.06)
Basic net income (loss) per share attributable to Titan and applicable common stockholders
$
0.09 
$
(0.38)
$
(0.07)
$
(0.01)
Diluted net loss from continuing operations per share
$
(0.02)
$
(0.43)
$
(0.11)
$
(0.06)
Diluted net income (loss) per share attributable to Titan and applicable common stockholders
$
0.09 
$
(0.38)
$
(0.07)
$
(0.01)
Average common shares and equivalents outstanding:
Basic
64,384 
64,072 
63,722 
63,283 
Diluted
64,504 
64,072 
63,722 
63,283 



TITAN INTERNATIONAL, INC.
Unaudited Condensed Consolidated Statements of Cash Flows
Recast for Discontinued Operations
(All amounts in thousands)
Three months ended
Cash flows from operating activities:
June 30, 2026
March 31, 2026
June 30, 2025
March 31, 2025
Net income (loss)
$
6,340 
$
(24,250)
$
(3,604)
$
22 
Net income from discontinued operations, net of tax
7,602 
3,479 
3,242 
3,858 
Net loss from continuing operations
(1,262)
(27,729)
(6,846)
(3,836)
Adjustments to reconcile net loss to net cash provided by operating activities of continuing operations:
Depreciation and amortization
13,702 
13,592 
13,443 
12,868 
Restructuring and other charges
834 
25,142 
— 
— 
Deferred income tax (benefit) provision
(4,838)
1,155 
3,379 
(1,201)
(Gain) loss on fixed asset and investment sale
(20)
64 
(2)
40 
Stock-based compensation
1,221 
565 
1,405 
(925)
Issuance of stock under 401(k) plan
420 
418 
431 
396 
Foreign currency (gain) loss
(1,217)
1,464 
14,367 
3,180 
(Increase) decrease in assets:
Accounts receivable
24,481 
(84,724)
35,047 
(78,735)
Inventories
3,222 
7,736 
(12,895)
(2,318)
Prepaid and other current assets
(1,826)
955 
(2,759)
(359)
Other assets
(2,912)
(3,245)
(2,961)
(1,417)
Increase in liabilities:
Accounts payable
(6,162)
17,671 
(19,760)
39,282 
Other current liabilities
1,986 
5,903 
(9,067)
106 
Other liabilities
2,626 
569 
1,658 
410 
Net cash provided by (used for) operating activities of continuing operations
30,255 
(40,464)
15,440 
(32,509)
Net cash provided by (used for) operating activities of discontinued operations
8,894 
(6,062)
(1,127)
(6,082)
Net cash provided by (used for) operating activities
39,149 
(46,526)
14,313 
(38,591)
Cash flows from investing activities:
Capital expenditures
(8,628)
(10,397)
(8,697)
(13,503)
Proceeds (loss) from sale of fixed assets
843 
(25)
29 
182 
Net cash used for investing activities of continuing operations
(7,785)
(10,422)
(8,668)
(13,321)
Net cash used for investing activities of discontinued operations
(4,081)
(2,712)
(1,350)
(1,507)
Net cash used for investing activities
(11,866)
(13,134)
(10,018)
(14,828)
Cash flows from financing activities:
Proceeds from borrowings
17,362 
57,698 
28,327 
26,604 
Repayments of debt
(35,890)
(32,686)
(29,335)
(6,496)
Other financing activities
(22)
(195)
(133)
98 
Net cash (used for) provided by financing activities of continuing operations
(18,550)
24,817 
(1,141)
20,206 
Net cash (used for) provided by financing activities of discontinued operations
(889)
1,377 
(567)
(1,592)
Net cash (used for) provided by financing activities
(19,439)
26,194 
(1,708)
18,614 
Effect of exchange rate changes on cash
679 
1,849 
7,652 
13,261 
Net increase (decrease) in cash and cash equivalents
8,523 
(31,617)
10,239 
(21,544)
Cash and cash equivalents, beginning of period
171,262 
202,879 
174,430 
195,974 
Cash and cash equivalents, end of period
$
179,785 
$
171,262 
$
184,669 
$
174,430 
Supplemental information:
Interest paid
$
17,260 
$
3,396 
$
17,959 
$
3,209 
Income taxes paid, net of refunds received
4,299 
2,137 
4,714 
3,421 



The table below provides a reconciliation of net loss to EBITDA and adjusted EBITDA, which are non-GAAP financial measures, for the three months ended June 30, 2026, March 31, 2026, June 30, 2025 and March 31, 2025 (in thousands).

Three months ended
June 30, 2026
March 31, 2026
June 30, 2025
March 31, 2025
Net loss from continuing operations
$
(1,262)
$
(27,729)
$
(6,846)
$
(3,836)
Adjustments:
(Benefit) provision for income taxes
(1,032)
3,304 
621 
3,368 
Interest expense, excluding financing fees amortization
9,897 
9,972 
9,759 
9,592 
Depreciation and amortization
13,702 
13,592 
13,443 
12,868 
EBITDA from continuing operations
$
21,305 
$
(861)
$
16,977 
$
21,992 
Adjustments:
Foreign exchange loss
75 
321 
1,969 
819 
Restructuring and impairment expenses
834 
25,142 
— 
— 
Adjusted EBITDA from continuing operations
$
22,214 
$
24,602 
$
18,946 
$
22,811 
Adjusted EBITDA from discontinued operations
11,946 
6,754 
11,213 
8,012 
Adjusted EBITDA attributable to Titan and applicable to common shareholders
$
34,160 
$
31,356 
$
30,159 
$
30,823 

Filing Exhibits & Attachments

4 documents

Keep reading